LBel Paris Regression Jour is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Ventura International Ltd. The primary component is Avobenzone; Ensulizole; Octinoxate; Oxybenzone.
Product ID | 14783-049_35041b4f-d141-4cf0-91c9-829ff347fe90 |
NDC | 14783-049 |
Product Type | Human Otc Drug |
Proprietary Name | LBel Paris Regression Jour |
Generic Name | Avobenzone, Ensulizole, Octinoxate, And Oxybenzone |
Dosage Form | Cream |
Route of Administration | TOPICAL |
Marketing Start Date | 2010-08-15 |
Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
Application Number | part352 |
Labeler Name | Ventura International LTD |
Substance Name | AVOBENZONE; ENSULIZOLE; OCTINOXATE; OXYBENZONE |
Active Ingredient Strength | 1 g/50g; g/50g; g/50g; g/50g |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2010-08-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2010-08-15 |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2010-08-15 |
Inactivation Date | 2019-10-21 |
Ingredient | Strength |
---|---|
AVOBENZONE | 1 g/50g |
SPL SET ID: | 024de8f0-1d3a-4761-8674-5d1a8ac9133c |
Manufacturer | |
UNII |
NDC | Brand Name | Generic Name |
---|---|---|
14783-035 | LBel Paris Regression Jour | LBel Paris Regression Jour |
14783-055 | LBel Paris Regression Jour | LBel Paris Regression Jour |
14783-045 | LBel Paris Regression Jour | LBel Paris Regression Jour |
14783-039 | LBel Paris | Avobenzone, Ensulizole, Octinoxate, and Oxybenzone |
14783-049 | LBel Paris | Avobenzone, Ensulizole, Octinoxate, and Oxybenzone |
13537-025 | LBEL REGRESSION JOUR | Avobenzone, Ensulizole, Octinoxate, and Oxybenzone |
14783-025 | LBEL REGRESSION JOUR | Avobenzone, Ensulizole, Octinoxate, and Oxybenzone |